Results 101 to 110 of about 50,073 (291)
Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister +11 more
wiley +1 more source
DystoniaMyoclonus-Dystonia is a rare, neurological movement disorder, clinically characterized by myoclonic jerks and dystonic symptoms, such as cervical dystonia and writer’s cramp.
Feline Hamami +3 more
doaj +1 more source
Disorder of the Neuromuscular Junction as a Mimic of Focal Dystonia
Movement Disorders Clinical Practice, EarlyView.
Duncan Wilson +6 more
wiley +1 more source
Myoclonic Dystonia: A Common Phenomenology in the Pleomorphic Movements of Angelman Syndrome
Movement Disorders Clinical Practice, EarlyView.Abstract Background Angelman syndrome (AS) is a neurodevelopmental disorder characterized by developmental delay, intellectual disability, a sociable demeanor, and abnormal movements. People with AS often exhibit multiple types of abnormal movements, including nonepileptic myoclonus, tremor, and dystonia, which hamper attempts to identify phenomenology
Robert P. Carson +8 more
wiley +1 more source
Conference Report: The Torsion Dystonias: A summary of the Third Dystonia Workshop Vancouver, B.C. March 1980 [PDF]
, 1981 E. G. Harris
openalex +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Deep brain stimulation (DBS) targeting the subthalamic nucleus (STN) can effectively treat motor symptoms of Parkinson's disease (PD). However, optimal patient selection remains challenging due to the inadequacy of outcome predictors.
John R. Younce +3 more
wiley +1 more source